A new study from the Yale School of Public Health and other institutions has found that a diabetes drug called rosiglitazone may raise the risk of serious heart problems, especially heart failure.
Rosiglitazone is a type of medicine called a thiazolidinedione. It is used to help people with type 2 diabetes manage their blood sugar levels. While it can be effective in lowering blood sugar, doctors and scientists have long worried that it might also increase the chance of heart disease.
These concerns led to the drug being suspended in Europe, and its use was restricted in the United States. Since 2007, many studies have tried to find out whether rosiglitazone causes more heart attacks, but the results were mixed. One reason for the confusion was that earlier studies didn’t have access to detailed data about individual patients.
Now, a large new study has taken a deeper look. It’s the most complete analysis so far of how rosiglitazone affects heart health. The researchers looked at data from more than 130 clinical trials.
These trials involved over 48,000 adults who had taken the drug for at least 24 weeks. The study compared people who took rosiglitazone to those who took other medications or a placebo (a pill with no medicine in it).
The results were clear and concerning. People who took rosiglitazone had a 33% higher risk of having a serious heart problem. This includes heart attacks, heart failure, and even death from heart disease or other causes. Out of 11,837 people who took the drug, 274 had a heart-related event. In the comparison group of 9,319 people, only 219 had such events.
These findings show how important it is to use detailed patient data when checking the safety of a medicine. They also highlight the need for openness in clinical trials. When data is shared clearly, it helps doctors and researchers better understand the true risks and benefits of a treatment.
Even though rosiglitazone is still used in some parts of the world, this new study raises fresh concerns about its safety. People who take this drug should talk with their doctor about the risks. There may be other, safer medications that work just as well for controlling diabetes.
This study was published in the BMJ medical journal. It reminds us that all diabetes drugs need to be watched closely to make sure they do not cause long-term harm to the heart.
If you care about heart health, please read studies about top foods to love for a stronger heart, and why oranges may help fight obesity, diabetes, and heart disease.
For more health information, please see recent studies about simple guide to a 7-day diabetes meal plan, and why you should add black beans to your plate.
Copyright © 2025 Knowridge Science Report. All rights reserved.
